Exchange: NYSEMkt·Updated 05:59 AM EDT
IBO logo

IBO Impact BioMedical Inc.

$3.75
$0.12
(3.10%)
Pre-Market
Prev Close $3.87
Mkt Cap$33.06M
Vol12.00

About IBO

Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.
49

Neutral Sentiment

How do you feel about IBO?

TILResearch
Does anybody have a bull case at this point for $IBO? I understand they aren't exactly in a position of power to get a better deal but is there any reason to buy at this level? I'm thinking no but would love to hear somebody that thinks this is a decent time to buy pre-merger
johannn
$IBO We get to vote again—though it’s just for show, since Chan has already stolen/snatched the majority via $DSS. https://www.sec.gov/ix?doc=/Archives/edgar/data/0002078148/000149315226047960/formf-4a.htm
focafoca99
$IBO effected a 1-for-12.62 reverse stock split, consolidating 12.62 pre-split shares into one post-split share.

Advertisement|Remove ads.